TAH9901
ADHD (Methylphenidate transdermal patch)
Phase 1Active
Key Facts
Indication
ADHD (Methylphenidate transdermal patch)
Phase
Phase 1
Status
Active
Company
About TAHO Pharmaceuticals
TAHO Pharma delivers novel transdermal and oral‑film drug formats to address unmet patient needs across cardiovascular, neurology, and oncology markets.
View full company profile